Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$0.19 0.00 (-1.10%)
As of 05/4/2026

DHAC vs. ATPC, NIVF, BACK, BTTX, and UPHL

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Agape ATP (ATPC), NewGenIvf Group (NIVF), IMAC (BACK), Better Therapeutics (BTTX), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

How does Digital Health Acquisition compare to Agape ATP?

Digital Health Acquisition (NASDAQ:DHAC) and Agape ATP (NASDAQ:ATPC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Digital Health Acquisition has a net margin of 0.00% compared to Agape ATP's net margin of -149.90%. Digital Health Acquisition's return on equity of 0.00% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Agape ATP -149.90%-9.91%-9.29%

1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by company insiders. Comparatively, 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Digital Health Acquisition has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.92, indicating that its share price is 192% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Agape ATP
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Digital Health Acquisition has higher earnings, but lower revenue than Agape ATP.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Agape ATP$1.52M1.87-$2.28M-$14.50N/A

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
Agape ATP Neutral

Summary

Digital Health Acquisition beats Agape ATP on 6 of the 8 factors compared between the two stocks.

How does Digital Health Acquisition compare to NewGenIvf Group?

Digital Health Acquisition (NASDAQ:DHAC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
NewGenIvf Group N/A N/A N/A

NewGenIvf Group has higher revenue and earnings than Digital Health Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
NewGenIvf Group$4.73M0.08$9.88MN/AN/A

Digital Health Acquisition has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500.

1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, NewGenIvf Group had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Digital Health Acquisition. Digital Health Acquisition's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that Digital Health Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Digital Health Acquisition Neutral
NewGenIvf Group Neutral

Summary

NewGenIvf Group beats Digital Health Acquisition on 5 of the 7 factors compared between the two stocks.

How does Digital Health Acquisition compare to IMAC?

IMAC (NASDAQ:BACK) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
Digital Health Acquisition N/A N/A N/A

Digital Health Acquisition has lower revenue, but higher earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K2.05-$9.42M-$3.12N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

IMAC has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500.

5.8% of IMAC shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, IMAC's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
IMAC Neutral
Digital Health Acquisition Neutral

Summary

IMAC beats Digital Health Acquisition on 4 of the 5 factors compared between the two stocks.

How does Digital Health Acquisition compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
Digital Health Acquisition Neutral

Better Therapeutics has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500.

34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

Summary

Better Therapeutics beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does Digital Health Acquisition compare to UpHealth?

UpHealth (NYSE:UPHL) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

56.1% of UpHealth shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 34.2% of UpHealth shares are held by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

UpHealth has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Digital Health Acquisition Neutral

Digital Health Acquisition has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.47N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

Summary

UpHealth beats Digital Health Acquisition on 4 of the 4 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$680K$234.51M$994.74M$11.77B
Dividend YieldN/A3.76%4.69%5.26%
P/E RatioN/A2.274.2923.23
Price / SalesN/A0.1425.4875.49
Price / CashN/A123.30388.0053.90
Price / BookN/A26.666.596.69
Net IncomeN/A-$8.98M$1.76M$332.64M
7 Day Performance-11.15%0.15%1.05%2.01%
1 Month Performance-15.34%48.07%41.77%9.19%
1 Year Performance-84.65%10.37%-6.46%39.59%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$0.19
-1.1%
N/AN/A$680KN/AN/A2,021
ATPC
Agape ATP
0.4837 of 5 stars
$2.00
-12.7%
N/AN/A$2.29M$1.52MN/A40
NIVF
NewGenIvf Group
1.3653 of 5 stars
$1.96
flat
N/AN/A$480K$4.73MN/AN/A
BACK
IMAC
N/A$0.05
-9.1%
N/AN/A$177K$72.05KN/A180
BTTX
Better Therapeutics
N/A$0.00
flat
N/AN/A$4KN/AN/A40

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners